Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aP(gen) or combined TdaP(gen) vaccines

BACKGROUND: Recombinant pertussis vaccines inducing long-lasting immune responses could help to control the rise in pertussis. We here report on persisting antibody responses 2 and 3 years after booster vaccination with a new generation recombinant acellular pertussis vaccine. METHODS: Participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitisuttithum, Punnee, Dhitavat, Jittima, Sirivichayakul, Chukiat, Pitisuthitham, Arom, Sabmee, Yupa, Chinwangso, Pailinrut, Kerdsomboon, Chawanee, Fortuna, Librada, Spiegel, Jane, Chauhan, Mukesh, Poredi, Indrajeet Kumar, van den Biggelaar, Anita H.J., Wijagkanalan, Wassana, Viviani, Simonetta, Mansouri, Souad, Pham, Hong Thai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343263/
https://www.ncbi.nlm.nih.gov/pubmed/34386749
http://dx.doi.org/10.1016/j.eclinm.2021.100976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343263/
https://www.ncbi.nlm.nih.gov/pubmed/34386749
http://dx.doi.org/10.1016/j.eclinm.2021.100976

Ejemplares similares